Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Novavax (NVAX) Up as EMA Recommends COVID Jab for Adolescents
01:32pm, Friday, 24'th Jun 2022 Zacks Investment Research
EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to Novavax's (NVAX) COVID-19 vaccine for use in adolescents. The stock rises 13.9%.
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
01:19pm, Friday, 24'th Jun 2022 Zacks Investment Research
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
Cases climb in Southeast Asia and Europe in latest week as BA.4 and BA.5 subvariants take hold
12:14pm, Friday, 24'th Jun 2022 MarketWatch
The World Health Organization said COVID cases were lower overall in the week through June 19, but moved higher in Southeast Asia, the Eastern Mediterranean and the European regions as the BA.4 and BA
COVID cases surge again in Europe as Moderna says its booster candidate protects against BA.4 and BA.5 omicron subvariants
12:14pm, Friday, 24'th Jun 2022 MarketWatch
COVID cases are again surging in Europe, driven by the BA.4 and BA.5 subvariants of omicron that are deemed to be 10% to 15% more infectious than earlier variants and are spreading fast in Portugal, F
3 Stocks That Drove the Dow's Nearly 200-Point Gain
08:55pm, Thursday, 23'rd Jun 2022 The Motley Fool
Investors seem to be adapting to the reality of a recession on the horizon.
Dr. Fauci's COVID case was ‘mild’ thanks to being vaccinated and double-boosted, he says
08:14pm, Thursday, 23'rd Jun 2022 MarketWatch
‘All is well with Fauci’ the White House's chief medical adviser said during a COVID-19 Response Team briefing, He also took Paxlovid to treat his COVID case.
3 Dirt Cheap Dividend Stocks to Buy Hand Over Fist
03:15pm, Thursday, 23'rd Jun 2022 The Motley Fool
These stocks offer dividend yields ranging from 2% to an astronomical 7.1%.
Moderna (MRNA) Reveals New Data on Bivalent COVID Booster
02:06pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Moderna's (MRNA) bivalent COVID booster candidate exhibits a greater than a 5-fold boost in antibody responses against the Omicron subvariants BA.4 and BA.5 in a phase II/III study.
Merck's (MRK) Pneumococcal Vaccine Gets FDA Nod for Kids
12:39pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Merck's (MRK) Vaxneuvance vaccine includes pneumococcal serotypes 22F and 33F, which are not included in the currently licensed 13-valent conjugate vaccines.
Enanta Pharmaceuticals, which is developing its own COVID-19 antiviral, says Pfizer infringed on a patent with Paxlovid
11:46am, Thursday, 23'rd Jun 2022 MarketWatch
The biotech is seeking compensation.
Pfizer (PFE) Gains As Market Dips: What You Should Know
09:45pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Pfizer (PFE) closed the most recent trading day at $49.07, moving +2% from the previous trading session.
Biden pushes back after Chevron CEO says oil industry has been vilified: 'He's mildly sensitive'
04:01pm, Wednesday, 22'nd Jun 2022 MarketWatch
President Joe Biden addresses the move by health officials to authorize COVID vaccines for kids under 5, as well as some issues related to high gasoline prices.
Got $5,000? These 2 Growth Stocks Are Absurdly Cheap Buys
03:23pm, Wednesday, 22'nd Jun 2022 The Motley Fool
You'll get a lot of bang for your buck with these stocks.
U.S. to start vaccinating very young children this week, and panel to recommend overhauling healthcare system
12:09pm, Wednesday, 22'nd Jun 2022 MarketWatch
The U.S. will start vaccinating children below the age of 5 starting this week, after regulatory agencies approved the shots developed by Moderna and Pfizer and BioNTech over the weekend.
